URGN · UroGen Pharma Ltd.
Market Cap
$2.13B
Shares
48.88M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-14 | 214 | $48.12 | $10,298 |
| 2026-08-12 | 349 | $47.11 | $16,441 |
| 2026-08-11 | 842 | $46.31 | $38,993 |
| 2026-08-10 | 912 | $46.96 | $42,828 |
| 2026-08-07 | 351 | $45.60 | $16,006 |
| 2026-08-03 | 36 | $38.24 | $1,377 |
| 2026-07-16 | 109 | $39.80 | $4,338 |
| 2026-07-14 | 313 | $39.51 | $12,367 |
| 2026-07-13 | 313 | $38.56 | $12,069 |
| 2026-07-09 | 1,069 | $38.03 | $40,654 |
| 2026-07-01 | 15 | $36.80 | $552 |
| 2026-06-30 | 75 | $36.07 | $2,705 |
| 2026-06-29 | 156 | $34.54 | $5,388 |
| 2026-06-15 | 73 | $29.72 | $2,170 |
| 2026-06-12 | 9,583 | $29.50 | $282,699 |
| 2026-06-02 | 222 | $27.03 | $6,001 |
| 2026-06-01 | 81 | $28.13 | $2,279 |
Showing 1–17 of 17 settlements
Key facts
CIK
1668243
CUSIP
M96088105
13F (30d)
166 filings
166 filers
Visit website
Investor relations